Table 1

Demographic and clinical characteristics of HIT-positive and HIT-negative subjects

CharacteristicHIT positive (n = 21)HIT negative (n = 37)P value
Age, mean (range) 66 (39-89) 63 (39-80) .47 
Female gender, n (%) 9 (42.9) 19 (51.4) .59 
Race, n (%)   .39 
 White 16 (76.2) 23 (62.2)  
 Black 1 (4.8) 6 (16.2)  
 Other/unknown 4 (19.0) 8 (21.6)  
Patient population, n (%)   .06 
 Cardiovascular surgery 14 (66.7) 14 (37.8)  
 Surgery (noncardiovascular) 5 (23.8) 9 (24.3)  
 Medicine 2 (9.5) 13 (35.1)  
 Other 1 (2.7)  
Setting, n (%)   .22 
 Tertiary care hospital 18 (85.7) 26 (70.3)  
 Community hospital 3 (14.2) 11 (29.7)  
Platelet count × 109/L, median (range)* 50 (19-139) 69 (3-883) .29 
Recognized thrombosis, n (%)* 14 (66.7) 20 (54.1) .41 
4Ts score, median (interquartile range) 6 (5-7) 4 (3-5) <.0001 
Received treatment for HIT, n (%) 19 (90.5) 25 (67.6) .06 
CharacteristicHIT positive (n = 21)HIT negative (n = 37)P value
Age, mean (range) 66 (39-89) 63 (39-80) .47 
Female gender, n (%) 9 (42.9) 19 (51.4) .59 
Race, n (%)   .39 
 White 16 (76.2) 23 (62.2)  
 Black 1 (4.8) 6 (16.2)  
 Other/unknown 4 (19.0) 8 (21.6)  
Patient population, n (%)   .06 
 Cardiovascular surgery 14 (66.7) 14 (37.8)  
 Surgery (noncardiovascular) 5 (23.8) 9 (24.3)  
 Medicine 2 (9.5) 13 (35.1)  
 Other 1 (2.7)  
Setting, n (%)   .22 
 Tertiary care hospital 18 (85.7) 26 (70.3)  
 Community hospital 3 (14.2) 11 (29.7)  
Platelet count × 109/L, median (range)* 50 (19-139) 69 (3-883) .29 
Recognized thrombosis, n (%)* 14 (66.7) 20 (54.1) .41 
4Ts score, median (interquartile range) 6 (5-7) 4 (3-5) <.0001 
Received treatment for HIT, n (%) 19 (90.5) 25 (67.6) .06 
*

At time of HIT laboratory testing.

or Create an Account

Close Modal
Close Modal